Cited by

• Chemotherapy in the management of invasive bladder cancer. A review.

  Bush H, Thatcher N, Barnard R. Bush H, et al. Cancer Chemother Pharmacol. 1979;3(2):87-96. doi: 10.1007/BF00254978. Cancer Chemother Pharmacol. 1979. PMID: 389480 Review.
• Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer.

  Fallah F, Fallah M, Sajadi Nia RS. Fallah F, et al. Curr Urol. 2013 Jan;6(3):160-4. doi: 10.1159/000343532. Epub 2012 Dec 21. Curr Urol. 2013. PMID: 24917736 Free PMC article.
• Cytotoxic chemotherapy in carcinoma of the bladder: a review.

  Smith PH. Smith PH. J R Soc Med. 1980 Mar;73(3):205-7. doi: 10.1177/014107688007300310. J R Soc Med. 1980. PMID: 7230204 Free PMC article. No abstract available.
• Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats.

  Babaya K, Takahashi S, Momose H, Matsuki H, Sasaki K, Samma S, Ozono S, Hirao Y, Okajima E. Babaya K, et al. Urol Res. 1987;15(6):329-34. doi: 10.1007/BF00265661. Urol Res. 1987. PMID: 3433593
• The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.

  Dobrzecki W, Kaczmarek A. Dobrzecki W, et al. Int Urol Nephrol. 1977;9(2):145-9. doi: 10.1007/BF02082016. Int Urol Nephrol. 1977. PMID: 412808